Xtant Medical Holdings, Inc.
General ticker "XTNT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $88.2M (TTM average)
Xtant Medical Holdings, Inc. does not follow the US Stock Market performance with the rate: -31.9%.
Estimated limits based on current volatility of 6.6%: low 0.37$, high 0.43$
Factors to consider:
- Total employees count: 151 (-34.9%) as of 2025
- US accounted for 90.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Historical losses limit sustained profitability, Labor/talent shortage/retention, Regulatory and compliance, Litigation risks, Market competition
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.39$, 1.06$]
- 2026-12-31 to 2027-12-31 estimated range: [0.40$, 1.05$]
Financial Metrics affecting the XTNT estimates:
- Positive: with PPE of 25.5 at the end of fiscal year the price was low
- Positive: 4.60 < Operating profit margin, % of 5.44
- Positive: 11.37 < Operating cash flow per share per price, % of 11.46
- Positive: 3.48 < Return on assets ratio (scaled to [-100,100]) of 5.02
- Positive: 49.86 < Shareholder equity ratio, % of 54.12 <= 58.56
- Positive: Investing cash flow per share per price, % of 7.21 > 2.08
- Positive: Interest expense per share per price, % of 3.35 <= 4.56
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
Short-term XTNT quotes
Long-term XTNT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $91.30MM | $117.27MM | $133.93MM |
| Operating Expenses | $101.46MM | $129.34MM | $126.64MM |
| Operating Income | $-10.16MM | $-12.07MM | $7.28MM |
| Non-Operating Income | $9.12MM | $-4.19MM | $-0.28MM |
| Interest Expense | $2.94MM | $4.16MM | $3.67MM |
| R&D Expense | $1.34MM | $2.38MM | $2.10MM |
| Income(Loss) | $-1.04MM | $-16.26MM | $7.00MM |
| Taxes | $-1.70MM | $0.19MM | $2.03MM |
| Net Income(Loss)* | $0.66MM | $-16.45MM | $4.97MM |
| Stockholders Equity | $51.35MM | $42.96MM | $50.95MM |
| Inventory | $36.88MM | $38.63MM | $30.26MM |
| Assets | $92.61MM | $93.84MM | $94.14MM |
| Operating Cash Flow | $-9.52MM | $-11.90MM | $12.55MM |
| Capital expenditure | $1.46MM | $4.11MM | $2.38MM |
| Investing Cash Flow | $-24.78MM | $-3.73MM | $7.90MM |
| Financing Cash Flow | $19.69MM | $16.07MM | $-9.57MM |
| Earnings Per Share** | $0.01 | $-0.12 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.